Spelling suggestions: "subject:"betacells"" "subject:"metamodells""
81 |
INSIGHTS TO THE MECHANISM OF TYPE 2 DIABETES REMISSION FOLLOWING ROUX-EN-Y GASTRIC BYPASS SURGERYMosinski, J. David 01 June 2016 (has links)
No description available.
|
82 |
Understanding the Role of Hypusine Biosynthesis in Endocrine-Exocrine CrosstalkDale, Dorian J. 08 1900 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Traditionally, the exocrine and endocrine cellular compartments of the pancreas have been considered distinct functional systems. However, recent studies suggest a more intricate relationship between the exocrine and endocrine, which may impact pancreatic growth and health. Additionally, translational control mechanisms have been linked to organ development. Our lab has shown that the mRNA translation factor eukaryotic initiation factor 5A (eIF5A), when in its post-translationally modified “hypusinated” form, plays a role in pancreas development. The hypusination of eIF5A requires the rate-limiting enzyme deoxyhypusine synthase (Dhps) to post- translationally modify a critical lysine residue which in turn produces the active form of eIF5A that functions in mRNA translation. When we generated animals with a deletion of Dhps in the pancreatic progenitor cells, there was no alteration in islet mass but significant exocrine insufficiency at embryonic (E) day 18.5 concomitant with downregulation of proteins required for exocrine pancreas development and function. Resultantly these animals died by 6 weeks-of-age. These observations prompted the question, is the phenotype caused by the absence of hypusinated eIF5A or the increase of unhypusinated eIF5A? To address this, we generated a mouse model wherein Eif5a is deleted in the pancreas (eIF5A∆PANC) and these mutant animals also display exocrine insufficiency. Interestingly, beta cell mass is increased at E18.5, and the mutant animals maintain euglycemia and survive up to 2 years. Ongoing analyses are interrogating the differences between these animal models with the goal to determine if mRNA translation facilitates cellular communication between the exocrine and endocrine pancreas.
|
83 |
The role of two pore channels (TPCs) in pancreatic beta cell stimulus-secretion couplingHeister, Paula Maria January 2012 (has links)
This thesis presents an investigation into the role of the recently identified two pore channels (TPCs) in β-cell stimulus-secretion coupling. TPCs are the receptors for calcium mobilising messenger nicotinic acid adenine dinucleotide phosphate (NAADP) located in the membrane of acidic intracellular calcium stores. It is proposed that they are responsible for the ATP-sensitive potassium channel (Katp channel) independent pathway of stimulus-secretion coupling; and that this pathway is not subordinate to the KAT? channel dependent pathway; but an alternative explanation of stimulus-secretion coupling in its own right. The first section of this thesis presents a characterisation of sub-membrane cal- cium signals observed in primary mouse β-cells in response to glucose and the membrane-permeable acetoxymethyl ester form of NAADP (NAADP-AM) using the non-ratiometric fluorescent calcium indicator fluo-4 and total internal reflection (TIRF) microscopy. These are compared to global cytosolic calcium changes observed with epifluorescence microscopy. Factors affecting the shape and time course of re- sponses are investigated, and pharmacological tools used to provide evidence for the role of intracellular calcium release from acidic stores mediated by NAADP. Having characterised the calcium responses of β-cells using TIRF; the second part of the thesis examines the effects of knocking out TPC2 (single KO), or both TPC1 and TPC2 (DKO) on these responses; after an initial assessment of pancreatic islet and β-cell morphology using electron microscopy. Gender differences in β-cell responses to glucose and NAADP are assessed in both wild type and knockout animals. Finally, the third section presents the discovery of elementary calcium release events in pancreatic β-cells. The current project visualises what are likely the triggering events for the global calcium signals examined in sections one and two. They take the form of localised calcium release in response to NAADP-AM and glucose; akin to sparks and puffs observed by stimulation with cADPR and IP3. Optical quantal analysis demonstrates the quantal nature of the events and estimates the size of the unitary calcium release unit (CRU) for NAADP. .
|
84 |
Estudo da função de HSPB1 na citoproteção induzida pela prolactina em células beta pancreáticas / Study of HSPB1 function in the cytoprotection induced by prolactin in pancreatic beta cellsGomes, Vinícius de Morais 11 May 2016 (has links)
O transplante de ilhotas pancreáticas é uma terapia promissora para o tratamento da diabetes mellitus tipo 1 (DM1). No entanto, ilhotas transplantadas estão sujeitas à rejeição pelo sistema imune dos pacientes receptores, portanto faz-se necessário o desenvolvimento de mecanismos moleculares que protejam essas células. Estudos mostraram que o hormônio prolactina (PRL) é capaz de inibir a apoptose desencadeada por citocinas pró-inflamatórias sobre células beta pancreáticas e que este processo citoprotetor depende da presença da chaperona HSPB1. Foi observado que durante o desenvolvimento do DM1, as células beta pancreáticas sofrem estresse de retículo endoplasmático e que isso contribui para desencadear apoptose. O estresse de retículo endoplasmático é caracterizado pelo acúmulo de proteínas mal dobradas nessa organela resultando na ativação da resposta a proteínas mal dobradas (UPR) que tem como finalidade recuperar a homeostase celular. No presente estudo mostramos, pela primeira vez, que PRL foi capaz de proteger células beta pancreáticas contra estresse de retículo endoplasmático promovido tanto por citocinas pró-inflamatórias (TNFα, IFNγ e IL1β) quanto pelos estressores de retículo endoplasmático: tunicamicina e tapsigargina; e que HSPB1 é essencial nesse mecanismo de citoproteção. No contexto do DM1, esse hormônio parece ter um efeito modulador da UPR aumentando os níveis de BiP, antecipando a ativação de ATF6 e PERK, mantendo a via de PERK ativa por mais tempo, inibindo a via de IRE1α, e diminuindo os níveis de CHOP em tempos maiores. Coletivamente, os resultados aqui apresentados aprofundam os conhecimentos sobre a função de HSPB1, conduzindo para o desenvolvimento de estratégias que visam à atenuação da morte de células beta por meio da modulação de uma via de proteção endógena, a qual é independente da modulação do sistema imunológico. / The islet transplantation is a promising therapy for the treatment of type 1 diabetes mellitus (T1DM). However, transplanted islets are subject to rejection by the immune system of the recipient patients, therefore the development of molecular mechanisms that protect these cells is necessary. Studies have shown that the hormone prolactin (PRL) is capable of inhibiting apoptosis triggered by pro-inflammatory cytokines on pancreatic beta cells and that this cytoprotective process depends on the presence of the chaperone HSPB1. It was observed that during the development of type 1 diabetes, pancreatic beta cells undergo endoplasmic reticulum stress and that this contributes to trigger apoptosis. The endoplasmic reticulum stress is characterized by accumulation of misfolded proteins in this organelle resulting in the activation of unfolded protein response (UPR) that aims to restore cellular homeostasis. In the present study, we show for the first time that PRL was able to protect pancreatic beta cells against endoplasmic reticulum stress promoted by both pro-inflammatory cytokines (TNFα, IFNγ and IL1β) as the endoplasmic reticulum stressors: tunicamycin and thapsigargin; and HSPB1 is essential that cytoprotective mechanism. In the context of T1DM, PRL appears to have a modulating effect of the UPR by increasing the levels of BiP, anticipating the activation of ATF6 and PERK, keeping the PERK pathway active for longer, inhibiting the pathway IRE1α, and decreasing the levels of CHOP for longer times. Collectively, the results presented here deepen the knowledge of the HSPB1 function, leading to the development of strategies inducing attenuation of beta cells death through modulation of endogenous protection means, which are independent of the modulation of the immune system.
|
85 |
Genetic association of islet amyloid polypeptide (IAPP) encoding pathways in pancreatic beta-cells with type 2 diabetes complemented by functional study. / CUHK electronic theses & dissertations collectionJanuary 2011 (has links)
Lam, Kwok Lim. / "October 2010." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 142-173). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
|
86 |
Functional Studies of Genes Associated with Muscle Growth in Pigs and Hair Greying in HorsesJiang, Lin January 2012 (has links)
Domestic animals have become very different from their wild ancestors during domestication and animal breeding. This provides a good model to unravel the molecular mechanisms underlying phenotypic variation. In my thesis I have studied genes affecting two important traits, leanness in pigs and hair greying-associated melanoma in horses. In the first part of the thesis, I focused on an intronic mutation leading to more muscle growth and less fat deposition in domestic pigs to identify a transcription factor (TF) that binds to the regulatory element overlapping with the mutation. The aim has been to further study the function of the previously unknown TF in mouse myoblast cells and in insulin-producing cells (Paper I-III). We discovered a new TF ZBED6 binding to intron 3 of the IGF2 gene, in which a single nucleotide substitution in pigs abrogates the binding and causes increased leanness in domestic pigs. Silencing of ZBED6 expression in mouse myoblasts increased Igf2 expression, cell proliferation and migration, and myotube formation. This result is in line with the increased leanness phenotype in mutant pigs. Chromatin Immunoprecipitation-sequencing (ChIP-seq) using an anti-ZBED6 antibody identified 1200 ZBED6 target genes besides IGF2 and many are TFs controlling fundamental biological processes. In the first follow-up study we found ZBED6 mainly affected the expression of muscle protein genes by directly regulating Igf2 and Twist2 expression, in agreement with our previous observation of faster myotube formation in ZBED6-silenced cells. ChIP-seq with antibodies against six different histone modifications revealed that ZBED6 preferentially binds to active promoters and modulates transcriptional activity by a novel mechanism rather than by recruiting repressive histone modifications. The second follow-up study revealed that ZBED6 affects the morphology and insulin content and release in pancreatic ß cells. In the second part (Paper IV), we investigate the functional significance of an intronic duplication in the Syntaxin 17 (STX17) gene causing hair greying and melanoma in horses. We found two Microphtalmia-associated transcription factor (MITF) binding sites within the duplication and showed that the duplicated sequence up-regulates reporter gene expression in a melanocyte-specific manner both by reporter assays in mouse melanocytes and in transgenic zebrafish. These results established that the intronic duplication acts as a melanocyte-specific enhancer that becomes much stronger when it is duplicated.
|
87 |
Small-Molecule Suppressors of Cytokine-Induced Beta-Cell ApoptosisChou, Danny Hung-Chieh 28 February 2013 (has links)
Type-1 diabetes is caused by the autoimmune destruction of insulin-producing beta cells in the pancreas. Beta-cell apoptosis involves a complex set of signaling cascades initiated by \(interleukin-1\beta (IL-1\beta)\), \(interferon-\gamma (IFN-\gamma)\), and \(tumor necrosis factor-\alpha (TNF-\alpha)\). \(IL-1\beta\) and \(TNF-\alpha\) induce \(NF\kappa B\) expression, while \(IFN-\gamma\) induces STAT1 activation. These cytokines lead to a decrease of beta-cell function. The goal of this thesis is to identify small-molecule suppressors of cytokine-induced beta-cell apoptosis using high-throughput screening approach. Using the rat INS-1E beta-cell line, I developed an assay to measure cellular viability after 48 hours of cytokine treatment. I screened 29,760 compounds for their ability to suppress the negative effects of the cytokines. I identified several compounds to be suppressors of beta-cell apoptosis. These efforts led to the discovery of \(GSK-3\beta\) and HDAC3 as novel targets for suppressing beta-cell apoptosis. I also followed up on BRD0608, a novel suppressor that increased ATP levels and decreased caspase activity in the presence of cytokines. To follow up this compound, 35 analogs related to BRD0476 were synthesized using solid-phase synthesis and tested for their protective effects in the presence of cytokines. A structurally related analog, BRD0476, was found to be more potent and active in human islets, decreasing caspase activation and increasing insulin secretion after a 6-day treatment. I performed gene-expression profiling of INS-1E cells treated with the cytokine cocktail in the absence or presence of \(10\mu M\) BRD0476. Gene-set enrichment analysis revealed that the gene sets most significantly changed by BRD0476 involved cellular responses to \(IFN-\gamma\). I therefore assessed the effects of BRD0476 on STAT1 transcriptional activity. Cytokine treatment increased the reporter-gene luciferase activity, while co-treatment with BRD0476 reduced this activity significantly. To identify the intracellular target(s) of BRD0476, I collaborated with the Proteomics Platform in Broad Institute using SILAC (stable isotope labeling by amino acids in cell culture). SILAC is a mass spectrometry-based method to identify proteins that bind a small molecule attached to a bead. Deubiquitinase USP9X was pulled down by BRD0476. Knock-down of USP9X by siRNA phenocopied the protective effects of BRD0476. Binding assays were performed to identify interactions between BRD0476 and USP9X. / Chemistry and Chemical Biology
|
88 |
Insulin secretion dynamics of recombinant hepatic and intestinal cellsGulino, Angela Marie 31 March 2008 (has links)
Hepatic and intestinal endocrine cells are potentially helpful targets for recombinant insulin expression. As the two cell types exhibit different secretion kinetics,it has been hypothesized that a combination of the two would better approximate insulin secretion kinetics from normal, functioning beta-cells than either cell type alone. This hypothesis was tested using two hepatic cell lines transiently transduced with one of three adenoviruses for insulin expression along with a stably transfected recombinant intestinal L cell line.
The insulin secretion kinetics were analyzed for both the hepatic and intestinal cells to determine the potential of combining them to reproduce the insulin secretion kinetics of a normal, functioning beta-cell. It was observed that the two recombinant hepatic cell lines secreted insulin in a more sustained manner exhibiting slower release kinetics. They also exhibited an increase in insulin secretion when stimulated by the cocktail of nutrient secretagogues (glucose and meat hydrolysate) versus stimulating with only glucose. The cells transduced with the adenovirus containing an additional cytomegalovirus (CMV) promoter and green fluorescent protein (GFP) exhibited the
highest insulin secretion after stimulation, whereas the cells transduced with an adenovirus encoding for destabilized preproinsulin mRNA exhibited the lowest secretion rates.
The recombinant intestinal cell line (GLUTag-INS) secreted insulin with rapid kinetics upon stimulation, apparently due to the presence of secretory granules containing pre-synthesized insulin. The experiments demonstrated that the cells stimulated with medium containing only meat hydrolysate exhibited a significantly higher
insulin secretion relative to secretagogue-free controls. The insulin secretion was not
further enhanced when meat hydrolysate was combined with glucose.
|
89 |
Avaliação dos efeitos de diferentes concentrações de dexametasona sobre parametros fisiologicos de ilhotas pancreaticas / Evaluation of the effects of different dexamethasone concentyrations on physiological parameters in pancreatic isletsRafacho, Alex 12 August 2018 (has links)
Orientador: Jose Roberto Bosqueiro / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-12T18:48:58Z (GMT). No. of bitstreams: 1
Rafacho_Alex_D.pdf: 17852608 bytes, checksum: ee7b970220681b508fc5519d53e49655 (MD5)
Previous issue date: 2008 / Resumo: A resistência à insulina (RI) é uma condição que exige maiores níveis de insulina circulante e que normalmente são providenciados pelo aumento da função e população de células ß. A RI pode ser observada a partir de diversos modelos experimentais em roedores tais como os modelos transgênicos, de gravidez, submetidos às dietas hiperlipídicas e hipercalóricas e a partir de infusão venosa de glicose. Estes modelos têm sido úteis para a compreensão dos mecanismos compensatórios observados durante a RI. Os glicocorticóides são amplamente utilizados na indução farmacológica da RI em modelos animais e em seres humanos, com fins científicos. A ativação da sinalização da insulina e das proteínas reguladoras do ciclo celular é crucial para a função e crescimento das células ß adultas. No presente trabalho, apresentamos modelos para investigação da função e crescimento de células ß pancreáticas in vivo a partir da administração diária de três concentrações distintas de dexametasona (DEX) (0,1, 0,5 e 1,0 mg/kg, peso corpóreo, intraperitoneal - DEX 0.1, DEX 0.5 e DEX 1.0, respectivamente) por 5 dias consecutivos. A sensibilidade periférica à glicose e à insulina, parâmetros de secreção de insulina e histomorfométricos foram investigados. A análise dos níveis de proteínas relacionados à função e crescimento de células ß foi realizada por Western blotting. O tratamento com DEX induziu RI de maneira dose- dependente. Aumento da secreção de insulina em resposta à glicose foi observado tanto in vivo quanto ex vivo nos três grupos tratados com DEX. Ratos DEX 1.0, que apresentam hiperglicemia moderada e marcante hiperinsulinemia, exibiram aumento de 5,1 vezes na proliferação além de hipertrofia de células ß, com aumento significativo na massa de células ß comparado aos ratos CTL. Os ratos DEX 0.5, hiperinsulinêmicos, porém normoglicêmicos, também apresentaram aumento significante de 3,6 vezes na proliferação e modesta hipertrofia de células ß. Entretanto, os ratos DEX 0.1, que desenvolveram o menor grau de RI, compensaram à demanda de insulina apenas com aumento da função de células ß. Nenhuma alteração da freqüência de morte celular foi observada nas células ß dos três grupos DEX comparados ao grupo CTL. Foi observada ativação da via IRS-2/PI3- K/Akt/p70S6K, bem como da proteína retinoblastoma nas ilhotas do grupo DEX 1.0 e, em menor grau, no grupo DEX 0.5 quando comparados com as ilhotas do grupo CTL. Assim, aumentando a concentração de dexametasona induzem-se três graus de requerimento de insulina in vivo, servindo como modelo para investigação de alterações compensatórias em células ß. O aumento da demanda de insulina é compensado por aumento da função das células ß (em todos os GRUPOS DEX) e por hiperplasia e hipertrofia de células ß nos GRUPOS DEX 1.0 e DEX 0.5. Baseado nos presentes resultados concluímos que o aumento dos níveis circulantes de insulina parece ser o maior estímulo para proliferação e hipertrofia das células de células ß observado na RI induzida pela dexametasona. / Abstract: Insulin resistance (IR) is a condition that demand increased levels of circulating insulin that are normally provided by increase of ß-cell function and mass. The IR can be observed in several experimental rodent models such as transgenic, pregnancy, high-fat or high-caloric diet and from glucose infusion model. These models have aided in elucidating the compensatory mechanisms observed during the IR. The glucocorticoids are widely used to induce the pharmacological IR in animal models and in humans, with scientific purpose. Activation of insulin signaling and cell cycle proteins are crucial to the function and growth of adult ß-cells. At the present study, we showed models to investigation of pancreatic ß-cell function and growth in vivo from the daily administration of three different dexamethasone (DEX) concentration (0.1, 0.5 e 1.0 mg/kg, body weight, intraperitoneal - DEX 0.1, DEX 0.5 and DEX 1.0, respectively) for 5 consecutive days. The peripheral sensibility to glucose and insulin, insulin secretion and histomorphometrical parameters were investigated. The analyses of proteins related to ß -cell function and growth were done by Western blotting. DEX treatment induced IR in a dose-dependent manner. Incease of glucose-stimulated insulin secretion was observed in vivo as well as ex vivo in the three DEX groups. DEX 1.0 rats, that present moderate hyperglicemya and marked hyperinsulinemia, ehibited a 5.1-fold increase in ß-cell proliferation besides hypertrophy, with significant increase of ß -cell mass compared to CTL rats. DEX 0.5 rats, that are hiperinsulinemic and normoglicemic, also exhibited a significant 3.6-fold increase in ß-cell proliferation as well as ß -cell hypertophy. However, DEX 0.1 rats, which exhibited the lowest degree of insulin resistance, compensate for insulin
demand by improving only ß -cell function. No alteration in cell death frequency was noted in ß -cells from the three DEX groups compared to CTL group. Activation of IRS-2/PI3-K/Akt/p70S6K pathway as well as the retinoblastoma protein in islets from DEX 1.0 and, in lesser extend, in DEX 0.5 group was observed compared to islets from CTL group. Therefore, increasing doses of dexamethasone induce three different degrees of insulin requirement in living rats, serving as a model to investigate compensatory beta-cell alterations. The increased insulin demand is compensated by increase of ß-cell function (in all DEX groups) and ß -cell hyperplasia and hypertrophy in DEX 0.5 and DEX 1.0 groups. Based on the present results we concluded that the augmented levels of circulating insulin seem to be the major stimulus for ß-cell proliferation and hypertrophy observed in dexamethasone-induced insulin resistance. / Doutorado / Fisiologia / Doutor em Biologia Funcional e Molecular
|
90 |
Role of nitric oxide and viral products in pancreatic B-cell dysfunction and death / Role of nitric oxide and viral products in pancreatic beta-cell dysfunction and deathLiu, Dongbo 05 March 2004 (has links)
SUMMARY<p><p>Type 1 diabetes mellitus (T1DM) is an autoimmune disease caused by progressive destruction of insulin-producing pancreatic beta-cells. Both viral infections and the cytokines interleukin-1beta (IL-1beta) and interferon-gamma (IFN-gamma) have been suggested as potential mediators of beta-cell death in early T1DM. Nitric oxide (NO) is a highly diffusible, short-lived free radical gas, which plays a significant role in several physiological processes in a diversity of tissues and organisms. Prolonged exposure of rodent or human pancreatic beta-cells to combinations of cytokines induces the expression of the inducible form of nitric oxide synthase (iNOS) and Fas, NO production, and cell death. It also induces the expression of potential "defense" genes, such as manganese superoxide dismutase (MnSOD) and heat shock protein (hsp) 70. Recent studies have shown that NO, in addition to having cytotoxic actions, may also regulate gene transcription. It remains unclear whether NO mediates cytokine-induced gene expression and subsequent beta-cell death. Previous studies using NO synthase blockers yielded conflicting results, which may be due to non-specific effects of these agents. <p>In the first part of our work, we examined the role of NO in beta-cell dysfunction and death by using an iNOS knockout mice (iNOS-/-, background C57BL/6x129SvEv). We evaluated the effects of cytokines on gene expression, as determined by reverse transcriptase-polymerase chain reaction (RT-PCR), and viability, as determined by nuclear dyes, of pancreatic islet cells or fluorescence-activated cell sorter (FACS)-purified beta-cells isolated from iNOS knockout mice or their respective controls (C57BL/6x129SvEv). The combination of cytokines used was interleukin-1beta (50 U/ml) + gamma-interferon (1000 U/ml) + tumor necrosis factor-alpha (1000 U/ml). The lack of cytokine-induced iNOS activity in the iNOS-/- islet cells was confirmed by RT-PCR and nitrite determination. Cytokines induced a > 3-fold increase in Fas and MnSOD mRNA expression in wild-type (wt) and iNOS-/- islets. On the other hand, hsp 70 was induced in wt but not in iNOS-/- islets. Prolonged (6-9 days) exposure of wt islets to cytokines lead to an 80-90% decrease in islet cell viability, whereas viability decreased by only 10-30% in iNOS-/- islet cells. To determine the mode of cytokine-induced cell death, FACS-purified beta-cells were exposed to the same cytokines. After 9 days, the apoptosis index was similarly increased in wt (39 +/- 3%) and iNOS-/- (33 +/- 4 %) beta-cells. On the other hand, cytokines increased necrosis in wt (20 +/- 4 %) but not in iNOS-/- (7 +/- 3 %) beta-cells. From these data, we conclude that: 1) NO is required for cytokine-induced hsp 70 mRNA expression, but not for Fas and MnSOD expression; 2) cytokines induce both apoptosis and necrosis in mouse beta-cells; 3) cytokine-induced apoptosis is mostly NO-independent, whereas necrosis requires NO formation.<p>In the second part of our work, we examined the role of the viral product double-stranded RNA (dsRNA) in beta-cell dysfunction and death. DsRNA is produced by many viruses during their replicative cycle. We investigated whether dsRNA (here utilized as synthetic poly IC (PIC)) modifies the effects of IL-1beta and IFN-gamma on gene expression and viability of rat pancreatic beta-cells and the role of NO in this process. FACS-purified rat beta-cells were exposed for 6-16 h (study of gene expression by RT-PCR) or 6-9 days (study of viability by nuclear dyes) to PIC and/or IL-1beta or IFN-gamma. PIC increased the expression of Fas and Mn superoxide dismutase mRNAs by 5-10-fold. IL-1beta and a combination of PIC + IFN-gamma& / Doctorat en sciences biomédicales / info:eu-repo/semantics/nonPublished
|
Page generated in 0.046 seconds